Scantox is a GLP-accredited pre-clinical contract research organization originally founded in 1977. Since 2021 Scantox is owned by the Nordic based investment company Impilo. Our focus is on providing high quality work within pharmacology, toxicology and histopathology. We service both global and local partners and are considered world leading within minipig toxicology.
Location: Denmark, Region Zealand, Lille Skensved
Employees: 51-200
Investors 1
Mentions in press and media 5
| Date | Title | Description |
| 09.09.2024 | Scantox Group To Acquire Gentronix | Scantox, a Danish provider of in-vivo preclinical research services for the pharmaceutical and medical device industries, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic ... |
| 02.09.2024 | Impilo acquires Qufora in partnership with existing shareholders | Impilo acquires Qufora in partnership with existing shareholders Mon, Sep 02, 2024 10:30 CET Report this content September 2nd, 2024 Copenhagen, Denmark. The investment company Impilo is now the majority shareholder in the Danish medtech co... |
| 20.11.2023 | Scantox continues its growth journey with the acquisition of Solural Pharma | Scantox continues its growth journey with the acquisition of Solural Pharma Mon, Nov 20, 2023 14:30 CET Report this content Scantox A/S (“Scantox”) announces the acquisition of Solural Pharma (“Solural”) in Denmark. Scantox is the leading N... |
| 31.08.2023 | Scantox acquires Q&Q – strengthening its offering within bioanalytical services | Scantox acquires Q&Q – strengthening its offering within bioanalytical services Thu, Aug 31, 2023 15:30 CET Report this content Scantox A/S (“Scantox” or the “Company”), the leading Nordic GLP-compliant pre-clinical contract research or... |
| 01.09.2022 | Scantox acquires Timeline Bioresearch and Adlego Biomedical – strengthening its position as the leading Nordic provider of pre-clinical research services | Scantox acquires Timeline Bioresearch and Adlego Biomedical – strengthening its position as the leading Nordic provider of pre-clinical research services Thu, Sep 01, 2022 12:07 CET Report this content Scantox A/S (“Scantox” or the “Company... |